Mitochondrial function/dysfunction in white adipose tissue

Experimental Physiology

Volumn 99, Issue 9, 2014, Pages 1168-1178

  Boudina, Sihem ^a   Graham, Timothy E ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADIPOCYTOKINE; BRANCHED CHAIN AMINO ACID; CHLOROQUINE; FATTY ACID; GLYCEROL; INSULIN; REACTIVE OXYGEN METABOLITE; ROSIGLITAZONE;

ADIPOGENESIS; AMINO ACID METABOLISM; APOPTOSIS; AUTOPHAGY; BROWN ADIPOCYTE; BROWN ADIPOSE TISSUE; DIABETES MELLITUS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ESTERIFICATION; GLUCONEOGENESIS; GLYCERONEOGENESIS; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPOATROPHY; LIPOGENESIS; LIPOLYSIS; METABOLIC DISORDER; MITOCHONDRIAL DYNAMICS; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN SECRETION; REVIEW; WHITE ADIPOCYTE; WHITE ADIPOSE TISSUE; ANIMAL; ENERGY METABOLISM; LIPID METABOLISM; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ADIPOCYTES, WHITE; ADIPOSE TISSUE, WHITE; ANIMALS; ENERGY METABOLISM; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; LIPID METABOLISM; MITOCHONDRIA; MITOCHONDRIAL DISEASES; OBESITY; OXIDATIVE STRESS;

EID: 84908308427     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2014.081414     Document Type: Review

References (82)

1. Adams SH (2011). Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state. Adv Nutr 2, 445-456.
2. Ahmadian M, Abbott MJ, Tang T, Hudak CS, Kim Y, Bruss M, Hellerstein MK, Lee HY, Samuel VT, Shulman GI, Wang Y, Duncan RE, Kang C & Sul HS (2011). Desnutrin/ATGL is regulated by AMPK and is required for a brown adipose phenotype. Cell Metab 13, 739-748.
3. Baerga R, Zhang Y, Chen PH, Goldman S & Jin S (2009). Targeted deletion of autophagy-related 5 (atg5) impairs adipogenesis in a cellular model and in mice. Autophagy 5, 1118-1130.
4. Ballard FJ, Hanson RW & Leveille GA (1967). Phosphoenolpyruvate carboxykinase and the synthesis of glyceride-glycerol from pyruvate in adipose tissue. J Biol Chem 242, 2746-2750.
5. Botion LM, Kettelhut IC & Migliorini RH (1995). Increased adipose tissue glyceroneogenesis in rats adapted to a high protein, carbohydrate-free diet. Horm Metab Res 27, 310-313.
6. Carrière A, Carmona MC, Fernandez Y, Rigoulet M, Wenger RH, Pénicaud L & Casteilla L (2004). Mitochondrial reactive oxygen species control the transcription factor CHOP-10/GADD153 and adipocyte differentiation: a mechanism for hypoxia-dependent effect. J Biol Chem 279, 40462-40469.
7. Carrière A, Fernandez Y, Rigoulet M, Pénicaud L & Casteilla L (2003). Inhibition of preadipocyte proliferation by mitochondrial reactive oxygen species. FEBS Lett 550, 163-167.
8. Chattopadhyay M, Guhathakurta I, Behera P, Ranjan KR, Khanna M, Mukhopadhyay S & Chakrabarti S (2011). Mitochondrial bioenergetics is not impaired in nonobese subjects with type 2 diabetes mellitus. Metabolism 60, 1702-1710.
9. Cheng Y, Meng Q, Wang C, Li H, Huang Z, Chen S, Xiao F & Guo F (2010). Leucine deprivation decreases fat mass by stimulation of lipolysis in white adipose tissue and upregulation of uncoupling protein 1 (UCP1) in brown adipose tissue. Diabetes 59, 17-25.
10. Choo HJ, Kim JH, Kwon OB, Lee CS, Mun JY, Han SS, Yoon YS, Yoon G, Choi KM & Ko YG (2006). Mitochondria are impaired in the adipocytes of type 2 diabetic mice. Diabetologia 49, 784-791.
11. Collins S, Cao W & Robidoux J (2004). Learning new tricks from old dogs: β-adrenergic receptors teach new lessons on firing up adipose tissue metabolism. Mol Endocrinol 18, 2123-2131.
12. Czabotar PE, Lessene G, Strasser A & Adams JM (2014). Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol 15, 49-63.
13. Dahlman I, Forsgren M, Sjögren A, Nordström EA, Kaaman M, Näslund E, Attersand A & Arner P (2006). Downregulation of electron transport chain genes in visceral adipose tissue in type 2 diabetes independent of obesity and possibly involving tumor necrosis factor-α. Diabetes 55, 1792-1799.
14. De Pauw A, Tejerina S, Raes M, Keijer J & Arnould T (2009). Mitochondrial (dys)function in adipocyte (de)differentiation and systemic metabolic alterations. Am J Pathol 175, 927-939.
15. Ducluzeau PH, Priou M, Weitheimer M, Flamment M, Duluc L, Iacobazi F, Soleti R, Simard G, Durand A, Rieusset J, Andriantsitohaina R & Malthièry Y (2011). Dynamic regulation of mitochondrial network and oxidative functions during 3T3-L1 fat cell differentiation. J Physiol Biochem 67, 285-296.
16. Ernster L & Schatz G (1981). Mitochondria: a historical review. J Cell Biol 91, 227s-255s.
17. Fassina G, Dorigo P & Gaion RM (1974). Equilibrium between metabolic pathways producing energy: a key factor in regulating lipolysis. Pharmacol Res Commun 6, 1-21.
18. Felig P, Marliss E & Cahill GF Jr (1969). Plasma amino acid levels and insulin secretion in obesity. N Engl J Med 281, 811-816.
19. Flachs P, Rossmeisl M, Kuda O & Kopecky J (2013). Stimulation of mitochondrial oxidative capacity in white fat independent of UCP1: a key to lean phenotype. Biochim Biophys Acta 1831, 986-1003.
20. Franckhauser S, Muñoz S, Pujol A, Casellas A, Riu E, Otaegui P, Su B & Bosch F (2002). Increased fatty acid re-esterification by PEPCK overexpression in adipose tissue leads to obesity without insulin resistance. Diabetes 51, 624-630.
21. Frerman FE, Sabran JL, Taylor JL & Grossberg SE (1983). Leucine catabolism during the differentiation of 3T3-L1 cells. Expression of a mitochondrial enzyme system. J Biol Chem 258, 7087-7093.
22. Frohnert BI, Sinaiko AR, Serrot FJ, Foncea RE, Moran A, Ikramuddin S, Choudry U & Bernlohr DA (2011). Increased adipose protein carbonylation in human obesity. Obesity (Silver Spring) 19, 1735-1741.
23. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M & Shimomura I (2004). Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114, 1752-1761.
24. Galinier A, Carrière A, Fernandez Y, Carpéné C, André M, Caspar-Bauguil S, Thouvenot JP, Périquet B, Pénicaud L & Casteilla L (2006). Adipose tissue proadipogenic redox changes in obesity. J Biol Chem 281, 12682-12687.
25. Goodman HM (1963). Effects of growth hormone on leucine metabolism in adipose tissue in vitro. Endocrinology 73, 421-426.
26. Harper AE, Miller RH & Block KP (1984). Branched-chain amino acid metabolism. Annu Rev Nutr 4, 409-454.
27. Herman MA, She P, Peroni OD, Lynch CJ & Kahn BB (2010). Adipose tissue branched chain amino acid (BCAA) metabolism modulates circulating BCAA levels. J Biol Chem 285, 11348-11356.
28. Holm C, Osterlund T, Laurell H & Contreras JA (2000). Molecular mechanisms regulating hormone-sensitive lipase and lipolysis. Annu Rev Nutr 20, 365-393.
29. Huh JY, Kim Y, Jeong J, Park J, Kim I, Huh KH, Kim YS, Woo HA, Rhee SG, Lee KJ & Ha H (2012). Peroxiredoxin 3 is a key molecule regulating adipocyte oxidative stress, mitochondrial biogenesis, and adipokine expression. Antioxid Redox Signal 16, 229-243.
30. Ichihara A & Koyama E (1966). Transaminase of branched chain amino acids. I. Branched chain amino acids-α-ketoglutarate transaminase. J Biochem 59, 160-169.
31. Jeon MJ, Leem J, Ko MS, Jang JE, Park HS, Kim HS, Kim M, Kim EH, Yoo HJ, Lee CH, Park IS, Lee KU & Koh EH (2012). Mitochondrial dysfunction and activation of iNOS are responsible for the palmitate-induced decrease in adiponectin synthesis in 3T3L1 adipocytes. Exp Mol Med 44, 562-570.
32. Kitsy A, Carney S, Vivar JC, Knight MS, Pointer MA, Gwathmey JK & Ghosh S (2014). Effects of leucine supplementation and serum withdrawal on branched-chain amino acid pathway gene and protein expression in mouse adipocytes. PLoS ONE 9, e102615.
33. Kleiner S, Mepani RJ, Laznik D, Ye L, Jurczak MJ, Jornayvaz FR, Estall JL, Chatterjee Bhowmick D, Shulman GI & Spiegelman BM (2012). Development of insulin resistance in mice lacking PGC-1α in adipose tissues. Proc Natl Acad Sci U S A 109, 9635-9640.
34. Klingenspor M (2003). Cold-induced recruitment of brown adipose tissue thermogenesis. Exp Physiol 88, 141-148.
35. Koh EH, Park JY, Park HS, Jeon MJ, Ryu JW, Kim M, Kim SY, Kim MS, Kim SW, Park IS, Youn JH & Lee KU (2007). Essential role of mitochondrial function in adiponectin synthesis in adipocytes. Diabetes 56, 2973-2981.
36. Kopecký J, Clarke G, Enerbäck S, Spiegelman B & Kozak LP (1995). Expression of the mitochondrial uncoupling protein gene from the aP2 gene promoter prevents genetic obesity. J Clin Invest 96, 2914-2923.
37. Kopecký J, Rossmeisl M, Flachs P, Bardová K & Brauner P (2001). Mitochondrial uncoupling and lipid metabolism in adipocytes. Biochem Soc Trans 29, 791-797.
38. Kopecký J, Rossmeisl M, Hodný Z, Syrový I, Horáková M & Kolárová P (1996). Reduction of dietary obesity in aP2-Ucp transgenic mice: mechanism and adipose tissue morphology. Am J Physiol Endocrinol Metab 270, E776-E786.
39. Kovsan J, Blüher M, Tarnovscki T, Klöting N, Kirshtein B, Madar L, Shai I, Golan R, Harman-Boehm I, Schön MR, Greenberg AS, Elazar Z, Bashan N & Rudich A (2011). Altered autophagy in human adipose tissues in obesity. J Clin Endocrinol Metab 96, E268-E277.
40. Kusminski CM, Holland WL, Sun K, Park J, Spurgin SB, Lin Y, Askew GR, Simcox JA, McClain DA, Li C & Scherer PE (2012). MitoNEET-driven alterations in adipocyte mitochondrial activity reveal a crucial adaptive process that preserves insulin sensitivity in obesity. Nat Med 18, 1539-1549.
41. Kusminski CM & Scherer PE (2012). Mitochondrial dysfunction in white adipose tissue. Trends Endocrinol Metab 23, 435-443.
42. Langin D (2006). Adipose tissue lipolysis as a metabolic pathway to define pharmacological strategies against obesity and the metabolic syndrome. Pharmacol Res 53, 482-491.
43. Loh K, Deng H, Fukushima A, Cai X, Boivin B, Galic S, Bruce C, Shields BJ, Skiba B, Ooms LM, Stepto N, Wu B, Mitchell CA, Tonks NK, Watt MJ, Febbraio MA, Crack PJ, Andrikopoulos S & Tiganis T (2009). Reactive oxygen species enhance insulin sensitivity. Cell Metab 10, 260-272.
44. Martin BR & Denton RM (1970). The intracellular localization of enzymes in white-adipose-tissue fat-cells and permeability properties of fat-cell mitochondria. Transfer of acetyl units and reducing power between mitochondria and cytoplasm. Biochem J 117, 861-877.
45. Nedergaard J, Cannon B & Lindberg O (1977). Microcalorimetry of isolated mammalian cells. Nature 267, 518-520.
46. Novikoff AB, Novikoff PM, Rosen OM & Rubin CS (1980). Organelle relationships in cultured 3T3-L1 preadipocytes. J Cell Biol 87, 180-196.
47. Olswang Y, Cohen H, Papo O, Cassuto H, Croniger CM, Hakimi P, Tilghman SM, Hanson RW & Reshef L (2002). A mutation in the peroxisome proliferator-activated receptor γ-binding site in the gene for the cytosolic form of phosphoenolpyruvate carboxykinase reduces adipose tissue size and fat content in mice. Proc Natl Acad Sci U S A 99, 625-630.
48. Ost A, Svensson K, Ruishalme I, Brännmark C, Franck N, Krook H, Sandström P, Kjolhede P & Strålfors P (2010). Attenuated mTOR signaling and enhanced autophagy in adipocytes from obese patients with type 2 diabetes. Mol Med 16, 235-246.
49. Pardo R, Enguix N, Lasheras J, Feliu JE, Kralli A & Villena JA (2011). Rosiglitazone-induced mitochondrial biogenesis in white adipose tissue is independent of peroxisome proliferator-activated receptor γ coactivator-1α. PLoS ONE 6, e26989.
50. Patel MS & Hanson RW (1970). Carboxylation of pyruvate by isolated rat adipose tissue mitochondria. J Biol Chem 245, 1302-1310.
51. Patti ME & Corvera S (2010). The role of mitochondria in the pathogenesis of type 2 diabetes. Endocr Rev 31, 364-395.
52. Pietiläinen KH, Naukkarinen J, Rissanen A, Saharinen J, Ellonen P, Keränen H, Suomalainen A, Götz A, Suortti T, Yki-Järvinen H, Oresic M, Kaprio J & Peltonen L (2008). Global transcript profiles of fat in monozygotic twins discordant for BMI: pathways behind acquired obesity. PLoS Med 5, e51.
53. Prusiner SB, Cannon B, Ching TM & Lindberg O (1968). Oxidative metabolism in cells isolated from brown adipose tissue. 2. Catecholamine regulated respiratory control. Eur J Biochem 7, 51-57.
54. Reed N & Fain JN (1968). Stimulation of respiration in brown fat cells by epinephrine, dibutyryl-3', 5'-adenosine monophosphate, and m-chloro(carbonyl cyanide)phenylhydrazone. J Biol Chem 243, 2843-2848.
55. Reshef L, Hanson RW & Ballard FJ (1969). Glyceride-glycerol synthesis from pyruvate. Adaptive changes in phosphoenolpyruvate carboxykinase and pyruvate carboxylase in adipose tissue and liver. J Biol Chem 244, 1994-2001.
56. Rognstad R & Katz J (1969). The effect of 2, 4-dinitrophenol on adipose-tissue metabolism. Biochem J 111, 431-444.
57. Rong JX, Qiu Y, Hansen MK, Zhu L, Zhang V, Xie M, Okamoto Y, Mattie MD, Higashiyama H, Asano S, Strum JC & Ryan TE (2007). Adipose mitochondrial biogenesis is suppressed in db/db and high-fat diet-fed mice and improved by rosiglitazone. Diabetes 56, 1751-1760.
58. Rosenthal J, Angel A & Farkas J (1974). Metabolic fate of leucine: a significant sterol precursor in adipose tissue and muscle. Am J Physiol 226, 411-418.
59. Ross SR, Graves RA, Greenstein A, Platt KA, Shyu HL, Mellovitz B & Spiegelman BM (1990). A fat-specific enhancer is the primary determinant of gene expression for adipocyte P2 in vivo. Proc Natl Acad Sci U S A 87, 9590-9594.
60. Rossmeisl M, Syrový I, Baumruk F, Flachs P, Janovská P & Kopecký J (2000). Decreased fatty acid synthesis due to mitochondrial uncoupling in adipose tissue. FASEB J 14, 1793-1800.
61. Shapiro B & Wertheimer E (1948). The synthesis of fatty acids in adipose tissue in vitro. J Biol Chem 173, 725-728.
62. She P, Reid TM, Bronson SK, Vary TC, Hajnal A, Lynch CJ & Hutson SM (2007). Disruption of BCATm in mice leads to increased energy expenditure associated with the activation of a futile protein turnover cycle. Cell Metab 6, 181-194.
63. Sheldon H, Hollenberg CH & Winegrad AI (1962). Observations on the morphology of adipose tissue. I. The fine structure of cells from fasted and diabetic rats. Diabetes 11, 378-387.
64. Si Y, Palani S, Jayaraman A & Lee K (2007). Effects of forced uncoupling protein 1 expression in 3T3-L1 cells on mitochondrial function and lipid metabolism. J Lipid Res 48, 826-836.
65. Singh R, Xiang Y, Wang Y, Baikati K, Cuervo AM, Luu YK, Tang Y, Pessin JE, Schwartz GJ & Czaja MJ (2009). Autophagy regulates adipose mass and differentiation in mice. J Clin Invest 119, 3329-3339.
66. Starkov AA (2008). The role of mitochondria in reactive oxygen species metabolism and signaling. Ann N Y Acad Sci 1147, 37-52.
67. Steinfelder HJ & Joost HG (1983). Reversible reduction of insulin receptor affinity by ATP depletion in rat adipocytes. Biochem J 214, 203-207.
68. Sutherland LN, Capozzi LC, Turchinsky NJ, Bell RC & Wright DC (2008). Time course of high-fat diet-induced reductions in adipose tissue mitochondrial proteins: potential mechanisms and the relationship to glucose intolerance. Am J Physiol Endocrinol Metab 295, E1076-1083.
69. Tischler ME & Goldberg AL (1980). Leucine degradation and release of glutamine and alanine by adipose tissue. J Biol Chem 255, 8074-8081.
70. Tormos KV, Anso E, Hamanaka RB, Eisenbart J, Joseph J, Kalyanaraman B & Chandel NS (2011). Mitochondrial complex III ROS regulate adipocyte differentiation. Cell Metab 14, 537-544.
71. Valerio A, Cardile A, Cozzi V, Bracale R, Tedesco L, Pisconti A, Palomba L, Cantoni O, Clementi E, Moncada S, Carruba MO & Nisoli E (2006). TNF-α downregulates eNOS expression and mitochondrial biogenesis in fat and muscle of obese rodents. J Clin Invest 116, 2791-2798.
72. Vernochet C, Mourier A, Bezy O, Macotela Y, Boucher J, Rardin MJ, An D, Lee KY, Ilkayeva OR, Zingaretti CM, Emanuelli B, Smyth G, Cinti S, Newgard CB, Gibson BW, Larsson NG & Kahn CR (2012). Adipose-specific deletion of TFAM increases mitochondrial oxidation and protects mice against obesity and insulin resistance. Cell Metab 16, 765-776.
73. Villarroya J, Giralt M & Villarroya F (2009). Mitochondrial DNA: an up-and-coming actor in white adipose tissue pathophysiology. Obesity (Silver Spring) 17, 1814-1820.
74. Wang PW, Kuo HM, Huang HT, Chang AY, Weng SW, Tai MH, Chuang JH, Chen IY, Huang SC, Lin TK & Liou CW (2014). Biphasic response of mitochondrial biogenesis to oxidative stress in visceral fat of diet-induced obesity mice. Antioxid Redox Signal 20, 2572-2588.
75. Williams GS, Boyman L, Chikando AC, Khairallah RJ & Lederer WJ (2013). Mitochondrial calcium uptake. Proc Natl Acad Sci U S A 110, 10479-10486.
76. Williamson JR (1964). Adipose tissue. Morphological changes associated with lipid mobilization. J Cell Biol 20, 57-74.
77. Wilson-Fritch L, Burkart A, Bell G, Mendelson K, Leszyk J, Nicoloro S, Czech M & Corvera S (2003). Mitochondrial biogenesis and remodeling during adipogenesis and in response to the insulin sensitizer rosiglitazone. Mol Cell Biol 23, 1085-1094.
78. Wilson-Fritch L, Nicoloro S, Chouinard M, Lazar MA, Chui PC, Leszyk J, Straubhaar J, Czech MP & Corvera S (2004). Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone. J Clin Invest 114, 1281-1289.
79. Yin X, Lanza IR, Swain JM, Sarr MG, Nair KS & Jensen MD (2014). Adipocyte mitochondrial function is reduced in human obesity independent of fat cell size. J Clin Endocrinol Metab 99, E209-E216.
80. Yu YH & Zhu H (2004). Chronological changes in metabolism and functions of cultured adipocytes: a hypothesis for cell aging in mature adipocytes. Am J Physiol Endocrinol Metab 286, E402-E410.
81. Zhang Y, Goldman S, Baerga R, Zhao Y, Komatsu M & Jin S (2009). Adipose-specific deletion of autophagy-related gene 7 (atg7) in mice reveals a role in adipogenesis. Proc Natl Acad Sci U S A 106, 19860-19865.
82. Zhao Y, Yang J, Liao W, Liu X, Zhang H, Wang S, Wang D, Feng J, Yu L & Zhu WG (2010). Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity. Nat Cell Biol 12, 665-675.